Literature DB >> 29257012

Allograft-Prosthetic Composite Reconstruction for Massive Proximal Humeral Bone Loss in Reverse Shoulder Arthroplasty.

Joaquin Sanchez-Sotelo1, Eric R Wagner1, Franklin H Sim1, Matthew T Houdek1.   

Abstract

BACKGROUND: Reverse total shoulder arthroplasty (RTSA) performed in the setting of massive proximal humeral bone loss often requires special reconstructive techniques. Restoration of the proximal part of the humerus with an allograft provides a number of theoretical benefits, including implant support, restoration of humeral length, deltoid tensioning, and an opportunity to repair the posterior aspect of the cuff to improve strength in external rotation and repair of the subscapularis to improve stability. However, reverse allograft-prosthesis composites (APCs) are costly, are technically demanding to use, and can be compromised by progressive allograft resorption.
METHODS: Between 2005 and 2012, the lead author used an APC reconstruction in 8 primary and 18 revision RTSAs (26 patients; mean age, 62 years; mean body mass index, 27.9 kg/m). The indications for the primary RTSAs included severe proximal humeral bone loss after trauma (n = 5) and tumor resection (n = 3). The indications in the revision setting were failed hemiarthroplasty (n = 11), anatomic total shoulder arthroplasty (n = 4), and reverse arthroplasty (n = 3). The most common reason for revision was instability (n = 10). A compression plate was used for graft-to-host fixation in all shoulders. Shoulders were assessed for pain, motion, American Shoulder and Elbow Surgeons (ASES) score, Simple Shoulder Test (SST) score, Neer score, revision or reoperation, radiographic evidence of graft union or resorption, and implant fixation. The mean duration of follow-up was 4 years (range, 2 to 10 years).
RESULTS: RTSA using an APC construct resulted in substantial improvements in pain scores (p < 0.0001), elevation (p < 0.0001), and external rotation (p = 0.004). With the numbers available, there were no significant differences in clinical outcomes between primary and revision cases. No patients required revision surgery for nonunion at the host-allograft junction. The mean time to union was 7 months, with 1 patient requiring bone-grafting for delayed union. Other complications included dislocation, deep infection, graft fracture, and periprosthetic fracture distal to the previous APC construct in 1 patient each. The 2 and 5-year revision-free survival rate was 96%.
CONCLUSIONS: Reconstruction of proximal humeral bone loss with an APC at the time of primary or revision RTSA is safe and effective, with acceptable functional outcomes and complication rates. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2017        PMID: 29257012     DOI: 10.2106/JBJS.16.01495

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  13 in total

1.  CORR Insights®: Do Early Results of Proximal Humeral Allograft-Prosthetic Composite Reconstructions Persist at 5-year Followup?

Authors:  Matthew T Houdek
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

Review 2.  [Shoulder prosthesis replacement options : New implants, treatment algorithms and clinical results].

Authors:  D Seybold; T A Schildhauer; J Geßmann
Journal:  Orthopade       Date:  2018-05       Impact factor: 1.087

3.  Inducing life-like distal radius fractures in human cadaveric specimens: a tool for enhanced surgical training.

Authors:  Kilian Wegmann; Andreas Harbrecht; Michael Hackl; Stephan Uschok; Tim Leschinger; Lars P Müller
Journal:  Arch Orthop Trauma Surg       Date:  2019-12-05       Impact factor: 3.067

4.  What Is the Survival and Function of Modular Reverse Total Shoulder Prostheses in Patients Undergoing Tumor Resections in Whom an Innervated Deltoid Muscle Can Be Preserved?

Authors:  Giulia Trovarelli; Alessandro Cappellari; Andrea Angelini; Elisa Pala; Pietro Ruggieri
Journal:  Clin Orthop Relat Res       Date:  2019-11       Impact factor: 4.176

5.  [Effectiveness of simultaneous versus delayed repair of combined full-thickness rotator cuff rupture in proximal humerus fracture].

Authors:  Jiying Tang; Zhongliang Tao; Jun Li; Zongsheng Yin
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-09-15

6.  Allograft-Prosthetic Composite Reconstruction for Massive Proximal Humeral Bone Loss in Reverse Shoulder Arthroplasty.

Authors:  Joaquin Sanchez-Sotelo; Eric R Wagner; Matthew T Houdek
Journal:  JBJS Essent Surg Tech       Date:  2018-01-24

7.  Treatment of proximal humerus fractures in geriatric patients - Can pathological DEXA results help to guide the indication for allograft augmentation?

Authors:  Sascha Halvachizadeh; Till Berk; Thomas Rauer; Christian Hierholzer; Roman Pfeifer; Hans-Christoph Pape; Florin Allemann
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

8.  The Personalized Shoulder Reconstruction Assisted by 3D Printing Technology After Resection of the Proximal Humerus Tumours.

Authors:  Hongzhi Hu; Weijian Liu; Qianwen Zeng; Shangyu Wang; Zhicai Zhang; Jianxiang Liu; Yingze Zhang; Zengwu Shao; Baichuan Wang
Journal:  Cancer Manag Res       Date:  2019-12-23       Impact factor: 3.989

Review 9.  The modern reverse shoulder arthroplasty and an updated systematic review for each complication: part I.

Authors:  Sarav S Shah; Benjamin T Gaal; Alexander M Roche; Surena Namdari; Brian M Grawe; Macy Lawler; Stewart Dalton; Joseph J King; Joshua Helmkamp; Grant E Garrigues; Thomas W Wright; Bradley S Schoch; Kyle Flik; Randall J Otto; Richard Jones; Andrew Jawa; Peter McCann; Joseph Abboud; Gabe Horneff; Glen Ross; Richard Friedman; Eric T Ricchetti; Douglas Boardman; Robert Z Tashjian; Lawrence V Gulotta
Journal:  JSES Int       Date:  2020-09-07

Review 10.  The modern reverse shoulder arthroplasty and an updated systematic review for each complication: part II.

Authors:  Sarav S Shah; Alexander M Roche; Spencer W Sullivan; Benjamin T Gaal; Stewart Dalton; Arjun Sharma; Joseph J King; Brian M Grawe; Surena Namdari; Macy Lawler; Joshua Helmkamp; Grant E Garrigues; Thomas W Wright; Bradley S Schoch; Kyle Flik; Randall J Otto; Richard Jones; Andrew Jawa; Peter McCann; Joseph Abboud; Gabe Horneff; Glen Ross; Richard Friedman; Eric T Ricchetti; Douglas Boardman; Robert Z Tashjian; Lawrence V Gulotta
Journal:  JSES Int       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.